First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis
{{output}}
Objective: To evaluate the optimal first-line treatment options for programmed death-ligand 1 (PD-L1) negative lung adenocarcinoma (LUAD) patients without common gene-alterations. ... ...
